Gilead's remdesivir reduces COVID-19 mortality risk- data

FILE PHOTO: Remdesivir, a drug used in the treatment of the coronavirus disease (COVID-19), is seen at Eva Pharma facility in Cairo, Egypt June 1, 2021. REUTERS/Mohamed Abd El Ghany(Reuters) – Gilead Sciences Inc said an analysis showed its antiviral remdesivir reduced mortality rates in hospitalized patients with COVID-19 and…